These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 7834190)

  • 1. Effects of the calcium channel blockers, diltiazem and Ro 40-5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing-induced heart failure.
    Su J; Renaud N; Carayon A; Crozatier B; Hittinger L
    Br J Pharmacol; 1994 Oct; 113(2):395-402. PubMed ID: 7834190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term hemodynamic effects of mibefradil in dogs with chronic heart failure: comparison with diltiazem.
    Shimoyama H; Sabbah HN; Tanimura M; Borzak S; Goldstein S
    J Pharmacol Exp Ther; 1998 May; 285(2):746-52. PubMed ID: 9580622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic profile of Ro 40-5967 in conscious rats: comparison with diltiazem, verapamil, and amlodipine.
    Véniant M; Clozel JP; Hess P; Wolfgang R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S55-8. PubMed ID: 1725005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ro 40-5967, in contrast to diltiazem, does not reduce left ventricular contractility in rats with chronic myocardial infarction.
    Véniant M; Clozel JP; Hess P; Wolfgang R
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):277-84. PubMed ID: 1709233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation.
    Billman GE
    Eur J Pharmacol; 1992 Dec; 229(2-3):179-87. PubMed ID: 1490522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of exercise-induced regional contractile dysfunction in dogs using a novel calcium channel blocker (Ro 40-5967).
    Guth BD
    Cardiovasc Drugs Ther; 1992 Apr; 6(2):167-71. PubMed ID: 1390329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts.
    Orito K; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of an endothelin-1 receptor antagonist bosentan at different stages of heart failure in conscious dogs.
    Choussat R; Hittinger L; Barbe F; Maistre G; Carayon A; Crozatier B; Su J
    Cardiovasc Res; 1998 Sep; 39(3):580-8. PubMed ID: 9861300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
    Billman GE; Hamlin RL
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of signal Ca2+ in dog coronary arterial vascular muscle cells by Ro 40-5967.
    Mishra SK; Hermsmeyer K
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):1-7. PubMed ID: 8078332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of calcium blockers on the performance of left and right ventricles during acute hypoxia].
    Zhou ZN; Gu LM; Yuan F; Xiao Y
    Sheng Li Xue Bao; 1992 Jun; 44(3):237-43. PubMed ID: 1455255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared.
    Nakaya H; Schwartz A; Millard RW
    Circ Res; 1983 Mar; 52(3):302-11. PubMed ID: 6825222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.
    Udvary E; Papp JG; Végh A
    Br J Pharmacol; 1995 Feb; 114(3):656-61. PubMed ID: 7735692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity.
    Lindqvist M; Kahan T; Melcher A; Ekholm M; Hjemdahl P
    J Hypertens; 2007 Jan; 25(1):169-75. PubMed ID: 17143189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and cardiac effects of the selective T-type and L-type calcium channel blocking agent mibefradil in patients with varying degrees of left ventricular systolic dysfunction.
    Rousseau MF; Hayashida W; van Eyll C; Hess OM; Benedict CR; Ahn S; Chapelle F; Kobrin I; Pouleur H
    J Am Coll Cardiol; 1996 Oct; 28(4):972-9. PubMed ID: 8837576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts.
    Clozel JP; Véniant M; Osterrieder W
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):731-6. PubMed ID: 1963792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats.
    Sandmann S; Min JY; Meissner A; Unger T
    Cardiovasc Res; 1999 Oct; 44(1):67-80. PubMed ID: 10615391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of diltiazem and nitroprusside on left ventricular function in experimental chronic volume overload.
    Porter CB; Walsh RA; Badke FR; O'Rourke RA
    Circulation; 1983 Sep; 68(3):685-92. PubMed ID: 6872178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of calcium-blocking agents on sympathetic responses to acute haemorrhagic shock in dogs.
    Pollard BJ; Fletcher IR; Tait AR; Knight PR; Van der Spek AF
    Eur J Anaesthesiol; 1987 Sep; 4(5):369-74. PubMed ID: 3322825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.